---
title: "Performance Comparison of Commercial Iron Oxide Tracers for Magnetic Particle Imaging"
id: "biorxiv-11-comparative-evaluation-of-commercial-iron-oxide-particles-for-magnetic-particle"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-11-comparative-evaluation-of-commercial-iron-oxide-particles-for-magnetic-particle"
content_type: "clinical_feed_article"
specialty: "Radiology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1?rss=1"
published_at: "2026-09-22T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Performance Comparison of Commercial Iron Oxide Tracers for Magnetic Particle Imaging
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-11-comparative-evaluation-of-commercial-iron-oxide-particles-for-magnetic-particle
- **Specialty:** [Radiology](https://medichelpline.com/clinical-feed/radiology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1?rss=1)
- **Published At:** 2026-09-22T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Magnetic particle imaging (**MPI**) signal arises from the non-linear magnetic response of superparamagnetic iron oxide (SPIO) nanoparticles. - Optimization of **SPIO** tracers for MPI remains active; performance can be assessed by magnetic particle relaxometry (**MPR**) and image-based MPI metrics. - The study compared ten commercially available tracers that varied in magnetic core size, hydrodynamic diameter, and surface coating using MPR peak signal intensity and two 2D MPI image metrics: total signal and maximum signal intensity. - **Synomag-D** tracers produced the highest MPR peak signal intensities and highest maximum MPI signal per microgram of iron. - ProMag, a micron-sized iron oxide particle (MPIO), showed low MPR peak signal intensity but delivered the highest total MPI signal per microgram of iron. - A strong correlation existed between MPR peak signal intensity and MPI maximum signal intensity (R2 = 0.94), indicating MPR predicts maximum image signal well. - Correlation between MPR peak signal and MPI total signal was weak overall (R2 = 0.38); excluding MPIOs improved that correlation substantially (R2 = 0.91), suggesting MPIOs behave differently in image-based total signal. - The authors conclude MPR generally predicts tracer performance but does not fully recapitulate complex imaging conditions; therefore, combined MPR and image-based evaluation is recommended for comprehensive tracer assessment. - The article is a preprint and has not been peer reviewed. Funding sources reported included the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council. The authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=pANwLm4vvh2xesTWKmN6j2GtpWKIRcI1S4kMZQQrycg-1790112675.8022923-1.2.1.1-XpEiWoDcwPQVDg8jqsixT4NAMW1Fs1DdBPnZtOd9j3mj00jsFQVDFqwLve9wd6uc) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Comparative Evaluation of Commercial Iron Oxide Particles for Magnetic Particle Imaging Using Relaxometry and Image-Based Metrics Bijita Neupane, Paula J Foster doi: https://doi.org/10.64898/2026.09.15.751874 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Bijita Neupane University of Western Ontario * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bijita%2BNeupane%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Neupane%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ABijita%2BNeupane%2B) * For correspondence: bneupane@uwo.ca Paula J Foster University of Western Ontario * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Paula%2BJ%2BFoster%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Foster%20PJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APaula%2BJ%2BFoster%2B) * [Abstract](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5801243/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5801243/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5801243/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5801243/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract In magnetic particle imaging (MPI), signal is generated from the non-linear magnetic response of superparamagnetic iron oxide (SPIO) nanoparticles. The optimization of SPIOs for MPI is an active area of investigation. Tracer performance can be evaluated by magnetic particle relaxometry (MPR) and image-based metrics. This study characterized and compared the performance of ten commercially available tracers, spanning a broad range of magnetic core sizes, hydrodynamic diameters and surface coatings, using the peak signal intensity measured from MPR, and the total signal and maximum signal intensity measured from 2D MPI images. Synomag-D tracers exhibited the highest MPR peak signal intensities and highest maximum signal per µg iron. ProMag, a micron-sized iron oxide particle (MPIO), yielded a low MPR peak signal intensity but had the highest total MPI signal per µg of iron. A strong correlation was observed between MPR peak signal intensity and MPI maximum signal intensity (R2=0.94). In contrast, there was a weak correlation between MPR peak signal intensity and MPI total signal intensity (R2=0.38), though this correlation improved when MPIOs were excluded from the analysis (R2=0.91). While MPR generally predicts the tracer performance, it does not completely replicate the complex imaging conditions. As such, comprehensive tracer evaluation requires combining both MPR and image-based metrics. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared Canadian Institutes of Health Research Natural Sciences and Engineering Research Council Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.09.15.751873v1 "The heterogeneity of age-related muscle atrophy of lower limb muscles")[Next ](https://www.biorxiv.org/content/10.64898/2026.09.15.751870v1 "GO-Term Enrichment of Proteome-Scale Docking Profiles as a Biological Search-Space Reduction Layer for Protein Target Discovery") Posted September 22, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.09.15.751874v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/09/22/2026.09.15.751874.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Comparative Evaluation of Commercial Iron Oxide Particles for Magnetic Particle Imaging Using Relaxometry and Image-Based Metrics Bijita Neupane, Paula J Foster bioRxiv 2026.09.15.751874; doi: https://doi.org/10.64898/2026.09.15.751874 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.09.15.751874v1%26text%3DComparative%2520Evaluation%2520of%2520Commercial%2520Iron%2520Oxide%2520Particles%2520for%2520Magnetic%2520Particle%2520Imaging%2520Using%2520Relaxometry%2520and%2520Image-Based%2520Metrics "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.09.15.751874v1%26t%3DComparative%2520Evaluation%2520of%2520Commercial%2520Iron%2520Oxide%2520Particles%2520for%2520Magnetic%2520Particle%2520Imaging%2520Using%2520Relaxometry%2520and%2520Image-Based%2520Metrics "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.09.15.751874v1%26title%3DComparative%2520Evaluation%2520of%2520Commercial%2520Iron%2520Oxide%2520Particles%2520for%2520Magnetic%2520Particle%2520Imaging%2520Using%2520Relaxometry%2520and%2520Image-Based%2520Metrics%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.09.15.751874v1%26title%3DComparative%2520Evaluation%2520of%2520Commercial%2520Iron%2520Oxide%2520Particles%2520for%2520Magnetic%2520Particle%2520Imaging%2520Using%2520Relaxometry%2520and%2520Image-Based%2520Metrics "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.09.15.751874) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8019) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (18768) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (14916) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (44479) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22618) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (19754) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (26928) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (13984) * [Ecology](https://www.biorxiv.org/collection/ecology) (21023) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (25469) * [Genetics](https://www.biorxiv.org/collection/genetics) (16181) * [Genomics](https://www.biorxiv.org/collection/genomics) (23529) * [Immunology](https://www.biorxiv.org/collection/immunology) (18720) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (42544) * [Molecular Biology](https://www.biorxiv.org/collection/molecular-biology) (18089) * [Neuroscience](https://www.biorxiv.org/collection/neuroscience) (93565) * [Paleontology](https://www.biorxiv.org/collection/paleontology) (701) * [Pathology](https://www.biorxiv.org/collection/pathology) (2985) * [Pharmacology and Toxicology](https://www.biorxiv.org/collection/pharmacology-and-toxicology) (5102) * [Physiology](https://www.biorxiv.org/collection/physiology) (8124) * [Plant Biology](https://www.biorxiv.org/collection/plant-biology) (16015) * [Scientific Communication and Education](https://www.biorxiv.org/collection/scientific-communication-and-education) (2097) * [Synthetic Biology](https://www.biorxiv.org/collection/synthetic-biology) (4570) * [Systems Biology](https://www.biorxiv.org/collection/systems-biology) (10247) * [Zoology](https://www.biorxiv.org/collection/zoology) (2393) Reviews and Context x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments bioRxiv aims to provide a venue for anyone to comment on a bioRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by bioRxiv. bioRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the bioRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP bioRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post pe
## Related Clinical Research

- [Computational Pipeline for Retinal Capillary Blood Flow Measurement with Adaptive Optics Line Conf](https://medichelpline.com/clinical-feed/biorxiv-2-a-computational-pipeline-for-retinal-capillary-blood-flow-measurement-using.md)
- [RecallRefine: Coverage-Constrained Coarse-to-Fine Segmentation for Small 3D Lesions](https://medichelpline.com/clinical-feed/biorxiv-19-recallrefine-coverage-constrained-coarse-to-fine-segmentationfor-small-3d.md)
- [Fatigue in Parkinson’s Disease: Associations with Motor and Non‑Motor Symptoms](https://medichelpline.com/clinical-feed/pubmed-42773252.md) (DOI: 10.1007/s10072-026-09416-3)
- [CBT-I for Insomnia Linked to Slower Biological Aging in Older Adults](https://medichelpline.com/clinical-feed/medical-news-today-0-could-treating-insomnia-slow-biological-aging-study-finds-promising-link.md)
- [Genomic Profile of Early-Onset and Familial Parkinson's Disease in Latin America](https://medichelpline.com/clinical-feed/medrxiv-3-genomic-landscape-of-early-onset-and-familial-latin-american-parkinson-s.md)

## Navigation
- [← Back to Radiology Feed](https://medichelpline.com/clinical-feed/radiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.